<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Ther Med</journal-id><journal-id journal-id-type="iso-abbrev">Exp Ther Med</journal-id><journal-id journal-id-type="publisher-id">ETM</journal-id><journal-title-group><journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group><issn pub-type="ppub">1792-0981</issn><issn pub-type="epub">1792-1015</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25289071</article-id><article-id pub-id-type="pmc">4186338</article-id><article-id pub-id-type="doi">10.3892/etm.2014.1966</article-id><article-id pub-id-type="publisher-id">etm-08-05-1628</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>A novel combination of the Arndt endobronchial blocker and the laryngeal mask airway ProSeal&#x02122; provides one-lung ventilation for thoracic surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>LI</surname><given-names>QIONG</given-names></name><xref ref-type="aff" rid="af1-etm-08-05-1628">1</xref><xref rid="fn1-etm-08-05-1628" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>LI</surname><given-names>PEIYING</given-names></name><xref ref-type="aff" rid="af1-etm-08-05-1628">1</xref><xref rid="fn1-etm-08-05-1628" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name><surname>XU</surname><given-names>JIANGHUI</given-names></name><xref ref-type="aff" rid="af1-etm-08-05-1628">1</xref></contrib><contrib contrib-type="author"><name><surname>GU</surname><given-names>HUAHUA</given-names></name><xref ref-type="aff" rid="af1-etm-08-05-1628">1</xref></contrib><contrib contrib-type="author"><name><surname>MA</surname><given-names>QINYUN</given-names></name><xref ref-type="aff" rid="af2-etm-08-05-1628">2</xref></contrib><contrib contrib-type="author"><name><surname>PANG</surname><given-names>LIEWEN</given-names></name><xref ref-type="aff" rid="af2-etm-08-05-1628">2</xref></contrib><contrib contrib-type="author"><name><surname>LIANG</surname><given-names>WEIMIN</given-names></name><xref ref-type="aff" rid="af1-etm-08-05-1628">1</xref><xref ref-type="corresp" rid="c1-etm-08-05-1628"/></contrib></contrib-group><aff id="af1-etm-08-05-1628"><label>1</label>Department of Anesthesiology, Huashan Hospital, Fudan University, Shanghai 200042, P.R. China</aff><aff id="af2-etm-08-05-1628"><label>2</label>Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai 200042, P.R. China</aff><author-notes><corresp id="c1-etm-08-05-1628">Correspondence to: Professor Weimin Liang, Department of Anesthesiology, Huashan Hospital, Fudan University, 12 Urumqi Road, Jingan, Shanghai 200042, P.R. China, E-mail: <email>weiminliangcn@126.com</email></corresp><fn id="fn1-etm-08-05-1628"><label>*</label><p>Contributed equally</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>15</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>9</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. --><volume>8</volume><issue>5</issue><fpage>1628</fpage><lpage>1632</lpage><history><date date-type="received"><day>14</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014, Spandidos Publications</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions><abstract><p>In this study, the feasibility and performance of the combination of the Arndt endobronchial blocker and the laryngeal mask airway (LMA) ProSeal&#x02122; in airway establishment, ventilation, oxygenation and lung isolation was evaluated. Fifty-five patients undergoing general anesthesia for elective thoracic surgeries were randomly allocated to group Arndt (n=26) or group double-lumen tube (DLT; n=29). Data concerning post-operative airway morbidity, ease of insertion, hemodynamics, lung collapse, ventilators, oxygenation and ventilation were collected for analysis. Compared with group DLT, group Arndt showed a significantly attenuated hemodynamic response to intubation (blood pressure, 149&#x000b1;31 vs. 115&#x000b1;16 mmHg; heart rate, 86&#x000b1;15 vs. 68&#x000b1;15 bpm), less severe injuries to the bronchus (injury score, 1.4&#x000b1;0.2 vs. 0.4&#x000b1;0.1) and vocal cords (injury score, 1.3&#x000b1;0.2 vs. 0.6&#x000b1;0.1), and lower incidences of post-operative sore throat and hoarseness. Furthermore, the novel combination of the Arndt and the LMA ProSeal showed similar ease of airway establishment, comparable ventilation and oxygenation performance, and an analogous lung isolation effect to DLT. The novel combined use of the Arndt endobronchial blocker and the LMA ProSeal can serve as a promising alternative for thoracic procedures requiring one-lung ventilation. The less traumatic properties and equally ideal lung isolation are likely to promote its use in rapidly spreading minimally invasive thoracic surgeries.</p></abstract><kwd-group><kwd>one-lung ventilation</kwd><kwd>laryngeal mask airway</kwd><kwd>Arndt endobronchial blocker</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The laryngeal mask airway (LMA) is a relatively new device that was brought into clinical practice in the 1980s. The LMA avoids undergoing laryngoscopy as well as all of its adverse effects. Additionally, it is less invasive to the respiratory tract and tracheal oedema, which may be caused by tracheal intubation, does not occur by using the LMA. Furthermore, it may be life saving in patients with malformations of the upper airway after a failure of tracheal intubation and mask ventilation. The laryngeal mask airway (LMA) is considered to be an extremely useful alternative to the endotracheal tube (ETT) in a number of clinical scenarios. Compared with conventional ETTs, the LMA causes less airway resistance, a decreased bronchoconstrictive reflex, less atelectasis and fewer pulmonary infections (<xref rid="b1-etm-08-05-1628" ref-type="bibr">1</xref>). However, the application of the LMA in thoracic anesthesia has been limited due to the requirement of one-lung ventilation (OLV), which appeared impossible for the LMA. Although reported as a useful adjunct in patients undergoing thoracotomy (<xref rid="b2-etm-08-05-1628" ref-type="bibr">2</xref>), the LMA alone has no possibility for OLV. In 1999, the Arndt endobronchial blocker, designed by Dr G.A. Arndt (<xref rid="b3-etm-08-05-1628" ref-type="bibr">3</xref>,<xref rid="b4-etm-08-05-1628" ref-type="bibr">4</xref>), emerged as a versatile alternative to double-lumen tubes (DLTs) to facilitate OLV in thoracic anesthesia (<xref rid="b5-etm-08-05-1628" ref-type="bibr">5</xref>&#x02013;<xref rid="b8-etm-08-05-1628" ref-type="bibr">8</xref>).</p><p>Previously, the combination of the LMA and the Arndt endobronchial blocker was reported in a pediatric scoliosis case (<xref rid="b9-etm-08-05-1628" ref-type="bibr">9</xref>). We hypothesized that the combination could also be applied safely to thoracic cases, bringing the advantages of fewer airway injuries, fewer fluctuations in hemodynamics and fewer limitations for OLV, enabling use in patients with difficult airways and in pediatric patients.</p><p>In the present prospective pilot study, the feasibility of OLV provided by the combination of the Arndt endobronchial blocker and the LMA ProSeal&#x02122; was assessed, and comparisons of the post-operative airway morbidity and the respiratory and hemodynamic data regarding the two strategies of OLV were performed.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Patient recruitment</title><p>The study was approved by the Human Ethics Committee of Huashan Hospital (Shanghai, China) and written informed consent was obtained from all the patients. Fifty-five adult patients (age, 20&#x02013;70 years; American Society of Anesthesiologists physical status, I-III) who were undergoing day-case thoracic surgeries were entered into the study prospectively. All patients were randomly allocated to group Arndt (n=26) or group DLT (n=29). Exclusion criteria included an age of &#x0003c;20 years, pre-operative hoarseness, increased risk of aspiration, mouth opening of &#x0003c;2.5 cm and surgeries predicted to have long durations.</p></sec><sec><title>Anesthesia procedure</title><p>Anesthetic monitoring, including electrocardiography, pulse oximetry, capnography and non-invasive blood pressure monitoring, was conducted prior to anesthesia induction and during the procedure. Prior to the induction of anesthesia, an arterial line was established for determining the baseline of arterial blood gas, blood pressure and heart rate. All patients were anesthetized by two chief residents who were experienced in the use of the LMA, the Arndt endobronchial blocker and DLT. General anesthesia was induced and maintained with target controlled infusion using a Graseby&#x02122; 3500 syringe pump (Smith Medical MD, Inc., St. Paul, MN, USA) of propofol at 4.0 &#x003bc;g/ml (plasma concentration) and continuous infusion of 3 &#x003bc;g/kg/h fentanyl and 0.8 mg/kg/h rocuronium. In group Arndt, the LMA ProSeal (LMA North America, Inc., San Diego, CA, USA) was placed and the patient was ventilated with pressure-controlled mode to achieve a tidal volume of 10 ml/kg (Primus Dr&#x000e4;ger, L&#x000fc;beck, Germany). An Arndt endobronchial blocker (Cook Medical Critical Care, Bloomington, IN, USA) was subsequently placed and guided by a 3.4-mm fiberoptic scope (FOB; BF type 3 C40; Olympus, Tokyo, Japan). In group DLT, the patients were intubated with DLTs and were ventilated with the same ventilator regimen. Positioning was confirmed by the same FOB. The blood pressures were read from the arterial line and the heart rates were recorded following placement of the airway devices and cuff position confirmation. A manometer for LMA (Mallinckrodt, Griesheim, Germany) was used to measure and control the cuff pressure between 55 and 60 cmH<sub>2</sub>O. Peak airway pressure and compliance were measured using an S/5 Compact Anesthesia Monitor (Datex-Ohmeda, Madison, WI, USA) and recorded while the patient was in both the supine and the lateral decubitus positions. Subsequent to patients being positioned to the lateral decubitus, the cuff position of the endobronchial blocker or of the DLT&#x02019;s endobronchial tube was checked again.</p></sec><sec><title>Evaluation of lung isolation</title><p>The evaluation of lung collapse and surgery exposure was performed by a thoracic surgeon blinded to the group assignment. Collapse of the lung was assessed as follows: 1, spontaneous; 2, assisted with suction; 3, manual. The conditions of surgery were rated as follows: 1, excellent (complete collapse with perfect surgical exposure); 2, fair (total collapse, but with residual air remaining in the lung); 3, poor (no collapse or partial collapse with interference in surgical exposure) (<xref rid="b10-etm-08-05-1628" ref-type="bibr">10</xref>).</p></sec><sec><title>Bronchoscopic examination</title><p>Upon completion of surgery, all patients underwent a bronchoscopic examination prior to emerging from anesthesia. Findings from the bronchoscopy and laryngoscopy were classified into bronchus, vocal cord and larynx injuries, and each injury class was scored as follows (<xref rid="b10-etm-08-05-1628" ref-type="bibr">10</xref>): 0, no changes; 1, redness; 2, edema; and 3, hematoma.</p></sec><sec><title>Assessment of post-operative airway morbidity</title><p>For the first three days after surgery, post-operative airway morbidity was rated by the anesthesia resident blinded to the group assignment. The assessment was performed in accordance with that described in the study by Knoll <italic>et al</italic> (<xref rid="b10-etm-08-05-1628" ref-type="bibr">10</xref>).</p></sec><sec><title>Statistical analysis</title><p>Patients were randomized using the sealed envelope system. All patients were stratified on gender and airway resistance information obtained from the pre-operative spirometry examination. Statistical analysis was performed using SPSS software version 14.0 (SPSS Inc., Chicago, IL, USA). Results were considered statistically significant when P&#x0003c;0.05. Data are expressed as the mean &#x000b1; standard deviation. The independent samples t-test and Mann-Whitney U test were used for analyzing parametric and nonparametric data as appropriate.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Fifty-five patients were enrolled in this study. The two groups were comparable in terms of age, male/female ratio, height, weight, pre-operative spirometry results and pre-operative hemodynamic parameters (<xref rid="tI-etm-08-05-1628" ref-type="table">Table I</xref>). In the context of the types of surgical procedures and the establishment of airways, the two groups were comparable (<xref rid="tII-etm-08-05-1628" ref-type="table">Tables II</xref> and <xref rid="tIII-etm-08-05-1628" ref-type="table">III</xref>).</p><p>Significantly attenuated cardiovascular responses following the insertion of the LMA and endobronchial blocker or DLT were observed in group Arndt compared with group DLT (P&#x0003c;0.05) (<xref rid="f1-etm-08-05-1628" ref-type="fig">Fig. 1</xref>). The cardiovascular responses induced by repositioning of the endobronchial blocker or the DLT were similar in the two groups. The respiratory parameters were comparable between the two groups with the exception of the peak airway pressure 5 min after OLV (<xref rid="tIV-etm-08-05-1628" ref-type="table">Table IV</xref>). No significant differences were identified in oxygenation condition between the two groups (<xref rid="tV-etm-08-05-1628" ref-type="table">Table V</xref>).</p><p>Bronchoscopic examination revealed that the injury scores of the bronchus and vocal cords were significantly higher in group DLT than those in group Arndt, while the larynx injury score was lower in group DLT (<xref rid="f2-etm-08-05-1628" ref-type="fig">Fig. 2A</xref>). The incidences of post-operative (three days after surgery) sore throat and hoarseness were significantly lower in group Arndt than those in group DLT (<xref rid="f2-etm-08-05-1628" ref-type="fig">Fig. 2B and C</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>DLTs are the most widely used devices for OLV; however, they have been reported to be associated with potential bronchus injury and sore throat (<xref rid="b10-etm-08-05-1628" ref-type="bibr">10</xref>). In cases of difficult airways, the intubation process of DLT may be further complicated when switching from a single-lumen tube with the help of the tube exchanger. The American Society of Anesthesiologists and the European Resuscitation Council have published algorithms naming the LMA as a primary option for the management of difficult and failed airways (<xref rid="b11-etm-08-05-1628" ref-type="bibr">11</xref>&#x02013;<xref rid="b13-etm-08-05-1628" ref-type="bibr">13</xref>). Enabling OLV to be performed with the LMA would mean that difficult airways could be easily handled. However, the LMA alone is not able to provide OLV for thoracic surgeries. The Arndt endobronchial blocker has been demonstrated to be a useful technique that produces comparable surgical exposure in thoracotomy when combined with a conventional single-lumen tube. The present study evaluated the possibility of the combined use of the LMA and Arndt endobronchial blocker as an alternative OLV strategy in thoracic surgeries.</p><p>In this study, it was revealed that the combination of the LMA and the Arndt endobronchial blocker was able to provide effective surgical exposure via OLV, and additionally was associated with reduced fluctuations in hemodynamic response (<xref rid="f1-etm-08-05-1628" ref-type="fig">Fig. 1</xref>), fewer airway injuries and less post-operative sore throat and hoarseness (<xref rid="f2-etm-08-05-1628" ref-type="fig">Fig. 2</xref>).</p><p>The instant surge of blood pressure or heart rate of patients receiving DLTs may be attributed to the sudden contact of the tube tip with the bronchial wall during intubation. The increase may be more extreme in patients with chronic hypertension, which is a common pre-existing physical condition in patients undergoing thoracotomy. Episodes of intra-operative hypertension or hypotension and tachycardia may predispose the patient to adverse post-operative neurological or cardiac outcomes, including increased risk of stroke or myocardial infarction. Maintaining maximum hemodynamic stability is one of the principle goals of anesthetic management. However, hemodynamic fluctuations are difficult to avoid during or following direct laryngoscopy and tracheal intubation. The LMA has particular appeal in such cases. The use of the LMA was reported to result in an attenuated cardiovascular response compared with that found with direct laryngoscopy and endotracheal intubation (<xref rid="b14-etm-08-05-1628" ref-type="bibr">14</xref>). In the present study, it was shown that the hemodynamic responses of group Arndt during LMA and endobronchial blocker insertion were less fluctuated than those of DLT intubation.</p><p>The results of the present study demonstrated that, with the exception of injuries to the larynx, post-operative airway injuries were significantly lower in group Arndt than group DLT. Incidences of sore throat and hoarseness were also notably lower in group Arndt than group DLT. These findings were consistent with those of Knoll <italic>et al</italic> (<xref rid="b10-etm-08-05-1628" ref-type="bibr">10</xref>), who compared the airway injury caused by DLT or the Arndt endobronchial blocker. The LMA ProSeal may cause laryngopharyngeal mucosal injury not only by the intensity of the LMA cuff pressure but also in a time-dependent manner. A histological study demonstrated that prolonged use of the LMA ProSeal in the pig for &#x0003c;9 h was associated with no or mild alterations in the laryngopharyngeal mucosa, whereas clear signs of mucosal injury were observed after &#x02265;12 h use (<xref rid="b15-etm-08-05-1628" ref-type="bibr">15</xref>). In the present study, due to the fact that the cuff pressure of the LMA was monitored and controlled by manometry, the higher risk of larynx injuries in group Arndt may have been caused by the prolonged use of the LMA due to the surgical time. Therefore, surgeries of long duration may not be recommended for the combination of the LMA and endobronchial blocker. However, for those less invasive day-case thoracic surgeries spreading rapidly throughout the world, this method may exhibit its advantages over DLTs.</p><p>Although not quantified, reduced secretions were observed in this study. Using this novel combination, it remains possible to perform tracheal suctioning through the internal channel of the FOB. In the present study, the FOB was advanced through the ventilation port of the LMA, the vocal cords and then to the trachea and bronchus. The process is relatively complicated, but suctioning can be performed under direct visualization. However, there was seldom requirement for suctioning in patients in the LMA group.</p><p>Complications resulting from the use of LMAs are known to be rare and were only present in 0.15% of &#x0003e;11,000 patients of all ages over a two-year period in a previous survey (<xref rid="b16-etm-08-05-1628" ref-type="bibr">16</xref>). When combined with the Arndt endobronchial blocker to achieve OLV, there may be concerns over the high pulmonary inflation pressures due either to increased airway resistance or to low lung compliance during OLV, which may lead to inadequate ventilation and gastric distension. It was reported in a previous study that the oropharyngeal leak pressure of the LMA ProSeal was 32 cmH<sub>2</sub>O (range, 12&#x02013;40 cmH<sub>2</sub>O) (<xref rid="b17-etm-08-05-1628" ref-type="bibr">17</xref>). In the present study, the peak airway pressure during OLV was 24.7&#x000b1;4.8 cmH<sub>2</sub>O in the Arndt group, which is far below the leak pressure of the LMA ProSeal. Certain patients, even with body weight &#x0003c;90 kg, may have an inadequate seal with a size 4 LMA, and would require a change to a size 5 LMA. This has been supported by a number of previous reports (<xref rid="b18-etm-08-05-1628" ref-type="bibr">18</xref>,<xref rid="b19-etm-08-05-1628" ref-type="bibr">19</xref>). Following the correction of the inadequate seal of the LMA at the beginning of anesthesia, the OLV process could be performed without further complications.</p><p>The intubation parameters did not demonstrate any significant difference between the two groups in the present study. All the anesthesiologists involved in this study were more familiar with the DLT technique, despite being trained in the combination technique for several cases previously. It can be predicted that once the combination technique is completely mastered, fewer difficulties may be experienced during the airway establishing process of thoracic anesthesia. However, further studies in this respect are warranted.</p><p>In conclusion, the combination of the LMA and the Arndt endobronchial blocker can facilitate airway establishment, even for patients with difficult airways, in addition to causing fewer hemodynamic fluctuations in the intubation process and leading to lower incidences of post-operative sore throat and hoarseness. With these advantages, this novel combination is likely to serve as an effective alternative OLV strategy for thoracic surgeries, particularly for those minimally invasive day-case surgeries that are gaining increasing attention throughout the world.</p></sec></body><back><ack><title>Acknowledgements</title><p>This study was supported by a grant from the Shanghai Natural Science Foundation (no. 13ZR1452200).</p></ack><ref-list><title>References</title><ref id="b1-etm-08-05-1628"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sener</surname><given-names>M</given-names></name><name><surname>Bilen</surname><given-names>A</given-names></name><name><surname>Bozdogan</surname><given-names>N</given-names></name><name><surname>Kilic</surname><given-names>D</given-names></name><name><surname>Arslan</surname><given-names>G</given-names></name></person-group><article-title>Laryngeal Mask Airway insertion with total intravenous anesthesia for transsternal thymectomy in patients with myasthenia gravis: report of 5 cases</article-title><source>J Clin Anesth</source><volume>20</volume><fpage>206</fpage><lpage>209</lpage><year>2008</year><pub-id pub-id-type="pmid">18502365</pub-id></element-citation></ref><ref id="b2-etm-08-05-1628"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferson</surname><given-names>DZ</given-names></name><name><surname>Nesbitt</surname><given-names>JC</given-names></name><name><surname>Nesbitt</surname><given-names>K</given-names></name><etal/></person-group><article-title>The laryngeal mask airway: a new standard for airway evaluation in thoracic surgery</article-title><source>Ann Thorac Surg</source><volume>63</volume><fpage>768</fpage><lpage>772</lpage><year>1997</year><pub-id pub-id-type="pmid">9066399</pub-id></element-citation></ref><ref id="b3-etm-08-05-1628"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname><given-names>GA</given-names></name><name><surname>Buchika</surname><given-names>S</given-names></name><name><surname>Kranner</surname><given-names>PW</given-names></name><name><surname>DeLessio</surname><given-names>ST</given-names></name></person-group><article-title>Wire-guided endobronchial blockade in a patient with a limited mouth opening</article-title><source>Can J Anaesth</source><volume>46</volume><fpage>87</fpage><lpage>89</lpage><year>1999</year><pub-id pub-id-type="pmid">10078410</pub-id></element-citation></ref><ref id="b4-etm-08-05-1628"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname><given-names>GA</given-names></name><name><surname>DeLessio</surname><given-names>ST</given-names></name><name><surname>Kranner</surname><given-names>PW</given-names></name><name><surname>Orzepowski</surname><given-names>W</given-names></name><name><surname>Ceranski</surname><given-names>B</given-names></name><name><surname>Valtysson</surname><given-names>B</given-names></name></person-group><article-title>One-lung ventilation when intubation is difficult - presentation of a new endobronchial blocker</article-title><source>Acta Anaesthesiol Scand</source><volume>43</volume><fpage>356</fpage><lpage>358</lpage><year>1999</year><pub-id pub-id-type="pmid">10081546</pub-id></element-citation></ref><ref id="b5-etm-08-05-1628"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arndt</surname><given-names>GA</given-names></name><name><surname>Kranner</surname><given-names>PW</given-names></name><name><surname>Rusy</surname><given-names>DA</given-names></name><name><surname>Love</surname><given-names>R</given-names></name></person-group><article-title>Single-lung ventilation in a critically ill patient using a fiberoptically directed wire-guided endobronchial blocker</article-title><source>Anesthesiology</source><volume>90</volume><fpage>1484</fpage><lpage>1486</lpage><year>1999</year><pub-id pub-id-type="pmid">10319801</pub-id></element-citation></ref><ref id="b6-etm-08-05-1628"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabon</surname><given-names>B</given-names></name><name><surname>Waltl</surname><given-names>B</given-names></name><name><surname>Leitgeb</surname><given-names>J</given-names></name><name><surname>Kapral</surname><given-names>S</given-names></name><name><surname>Zimpfer</surname><given-names>M</given-names></name></person-group><article-title>First experience with fiberoptically directed wire-guided endobronchial blockade in severe pulmonary bleeding in an emergency setting</article-title><source>Chest</source><volume>120</volume><fpage>1399</fpage><lpage>1402</lpage><year>2001</year><pub-id pub-id-type="pmid">11591587</pub-id></element-citation></ref><ref id="b7-etm-08-05-1628"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esp&#x000ed;</surname><given-names>C</given-names></name><name><surname>Garc&#x000ed;a-Guasch</surname><given-names>R</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>C</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>E</given-names></name><name><surname>Astudillo</surname><given-names>J</given-names></name></person-group><article-title>Selective lobar blockade using an arndt endobronchial blocker in 2 patients with respiratory compromise who underwent lung resection</article-title><source>Arch Bronconeumol</source><volume>43</volume><fpage>346</fpage><lpage>348</lpage><year>2007</year><comment>(In Spanish)</comment><pub-id pub-id-type="pmid">17583645</pub-id></element-citation></ref><ref id="b8-etm-08-05-1628"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>PY</given-names></name><name><surname>Gu</surname><given-names>HH</given-names></name><name><surname>Liang</surname><given-names>WM</given-names></name></person-group><article-title>Sequential one-lung ventilation using one Arndt endobronchial blocker in a pediatric patient undergoing bilateral, video-assisted thoracoscopic surgery (VATS)</article-title><source>J Clin Anesth</source><volume>21</volume><fpage>464</fpage><year>2009</year><pub-id pub-id-type="pmid">19833286</pub-id></element-citation></ref><ref id="b9-etm-08-05-1628"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name></person-group><article-title>One-lung ventilation using Proseal laryngeal mask airway and Arndt endobronchial blocker in paediatric scoliosis surgery</article-title><source>Br J Anaesth</source><volume>103</volume><fpage>902</fpage><lpage>903</lpage><year>2009</year><pub-id pub-id-type="pmid">19918029</pub-id></element-citation></ref><ref id="b10-etm-08-05-1628"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoll</surname><given-names>H</given-names></name><name><surname>Ziegeler</surname><given-names>S</given-names></name><name><surname>Schreiber</surname><given-names>JU</given-names></name><name><surname>Buchinger</surname><given-names>H</given-names></name><name><surname>Bialas</surname><given-names>P</given-names></name><etal/></person-group><article-title>Airway injuries after one-lung ventilation: a comparison between double-lumen tube and endobronchial blocker: a randomized, prospective, controlled trial</article-title><source>Anesthesiology</source><volume>105</volume><fpage>471</fpage><lpage>477</lpage><year>2006</year><pub-id pub-id-type="pmid">16931978</pub-id></element-citation></ref><ref id="b11-etm-08-05-1628"><label>11</label><element-citation publication-type="journal"><comment>No authors listed</comment><article-title>Practice guidelines for management of the difficult airway. A report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway</article-title><source>Anesthesiology</source><volume>78</volume><fpage>597</fpage><lpage>602</lpage><year>1993</year><pub-id pub-id-type="pmid">8457062</pub-id></element-citation></ref><ref id="b12-etm-08-05-1628"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benumof</surname><given-names>JL</given-names></name></person-group><article-title>Laryngeal mask airway and the ASA difficult airway algorithm</article-title><source>Anesthesiology</source><volume>84</volume><fpage>686</fpage><lpage>699</lpage><year>1996</year><pub-id pub-id-type="pmid">8659797</pub-id></element-citation></ref><ref id="b13-etm-08-05-1628"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroesen</surname><given-names>G</given-names></name></person-group><article-title>Guidelines for the advanced management of the airway and ventilation during resuscitation. A statement by the airway and ventilation management working group of the European Resuscitation Council, 1996 (Resuscitation 1996;31:201&#x02013;230)</article-title><source>Resuscitation</source><volume>35</volume><fpage>89</fpage><lpage>90</lpage><year>1997</year><pub-id pub-id-type="pmid">9259069</pub-id></element-citation></ref><ref id="b14-etm-08-05-1628"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marietta</surname><given-names>DR</given-names></name><name><surname>Lunn</surname><given-names>JK</given-names></name><name><surname>Ruby</surname><given-names>EI</given-names></name><name><surname>Hill</surname><given-names>GE</given-names></name></person-group><article-title>Cardiovascular stability during carotid endarterectomy: endotracheal intubation versus laryngeal mask airway</article-title><source>J Clin Anesth</source><volume>10</volume><fpage>54</fpage><lpage>57</lpage><year>1998</year><pub-id pub-id-type="pmid">9526939</pub-id></element-citation></ref><ref id="b15-etm-08-05-1628"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldmann</surname><given-names>K</given-names></name><name><surname>Dieterich</surname><given-names>J</given-names></name><name><surname>Roessler</surname><given-names>M</given-names></name></person-group><article-title>Laryngopharyngeal mucosal injury after prolonged use of the ProSeal LMA in a porcine model: a pilot study</article-title><source>Can J Anaesth</source><volume>54</volume><fpage>822</fpage><lpage>828</lpage><year>2007</year><pub-id pub-id-type="pmid">17934164</pub-id></element-citation></ref><ref id="b16-etm-08-05-1628"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verghese</surname><given-names>C</given-names></name><name><surname>Brimacombe</surname><given-names>JR</given-names></name></person-group><article-title>Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage</article-title><source>Anesth Analg</source><volume>82</volume><fpage>129</fpage><lpage>133</lpage><year>1996</year><pub-id pub-id-type="pmid">8712387</pub-id></element-citation></ref><ref id="b17-etm-08-05-1628"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Brimacombe</surname><given-names>J</given-names></name><name><surname>Kleinsasser</surname><given-names>A</given-names></name><name><surname>Brimacombe</surname><given-names>L</given-names></name></person-group><article-title>The Laryngeal Mask Airway ProSeal(TM) as a temporary ventilatory device in grossly and morbidly obese patients before laryngoscope-guided tracheal intubation</article-title><source>Anesth Analg</source><volume>94</volume><fpage>737</fpage><lpage>740</lpage><year>2002</year><pub-id pub-id-type="pmid">11867408</pub-id></element-citation></ref><ref id="b18-etm-08-05-1628"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimacombe</surname><given-names>JR</given-names></name></person-group><article-title>Positive pressure ventilation with the size 5 laryngeal mask</article-title><source>J Clin Anesth</source><volume>9</volume><fpage>113</fpage><lpage>117</lpage><year>1997</year><pub-id pub-id-type="pmid">9075035</pub-id></element-citation></ref><ref id="b19-etm-08-05-1628"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patki</surname><given-names>J</given-names></name><name><surname>Reddy</surname><given-names>KCN</given-names></name></person-group><article-title>Six hours positive pressure ventilation with size 5 laryngeal mask in a 55-kg patient</article-title><source>Indian J Anaesth</source><volume>54</volume><fpage>174</fpage><lpage>175</lpage><year>2010</year><pub-id pub-id-type="pmid">20661364</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-etm-08-05-1628" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Hemodynamic changes of the two groups. (A) Blood pressure measured following intubation (Post-intu) and patient positioning (Post-posi). (B) Heart rate measured following intubation and patient positioning. Significant differences between group Arndt and group DLT were noted in blood pressure and heart rate following intubation (<sup>*</sup>P&#x0003c;0.05). DLT, double-lumen tube.</p></caption><graphic xlink:href="ETM-08-05-1628-g00"/></fig><fig id="f2-etm-08-05-1628" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Post-operative airway injuries, sore throat and hoarseness. (A) The airway injuries were determined by bronchoscopy immediately subsequent to extubation and prior to patients&#x02019; awakening. The injury scores in the bronchus and vocal cords were significantly lower in the Arndt group, whereas the scores in the larynx were significantly lower in the DLT group. (B and C) Post-operative airway morbidity was obtained on the first three days after the surgery via the post-operative questionnaire. The incidences of sore throat and hoarseness were significantly lower in the Arndt group compared with those in the DLT group (<sup>*</sup>P&#x0003c;0.05). DLT, double-lumen tube.</p></caption><graphic xlink:href="ETM-08-05-1628-g01"/></fig><table-wrap id="tI-etm-08-05-1628" orientation="portrait" position="float"><label>Table I</label><caption><p>Demographic data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Variable</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group Arndt, n=26</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group DLT, n=29</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">55&#x000b1;15</td><td valign="top" align="center" rowspan="1" colspan="1">57&#x000b1;13</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (M/F)</td><td valign="top" align="center" rowspan="1" colspan="1">18/8</td><td valign="top" align="center" rowspan="1" colspan="1">17/12</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Height (cm)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">166&#x000b1;9</td><td valign="top" align="center" rowspan="1" colspan="1">167&#x000b1;9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Weight (kg)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">62&#x000b1;11</td><td valign="top" align="center" rowspan="1" colspan="1">64&#x000b1;10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FVC (%)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">83&#x000b1;18</td><td valign="top" align="center" rowspan="1" colspan="1">89&#x000b1;13</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">FEV1 (%)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">89&#x000b1;25</td><td valign="top" align="center" rowspan="1" colspan="1">89&#x000b1;14</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pre-op BP (mmHg)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">148&#x000b1;25</td><td valign="top" align="center" rowspan="1" colspan="1">143&#x000b1;22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pre-op HR (bpm)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">75&#x000b1;16</td><td valign="top" align="center" rowspan="1" colspan="1">76&#x000b1;10</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Smoking history (n)</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">14</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Surgery duration (h)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.3&#x000b1;1.7</td><td valign="top" align="center" rowspan="1" colspan="1">3.1&#x000b1;2.1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Anesthesia duration (h)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">3.7&#x000b1;1.9</td><td valign="top" align="center" rowspan="1" colspan="1">4.2&#x000b1;1.8</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OLV duration (h)<xref rid="tfn1-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.7&#x000b1;1.2</td><td valign="top" align="center" rowspan="1" colspan="1">1.8&#x000b1;1.1</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-etm-08-05-1628"><label>a</label><p>Values are presented as the mean &#x000b1; standard deviation.</p></fn><fn id="tfn2-etm-08-05-1628"><p>DLT, double-lumen tube; M/F, male to female ratio; FVC, forced vital capacity, percentage of predicted; FEV1, forced expiratory volume in the first second, percentage of predicted; pre-op BP, pre-operative blood pressure; pre-op HR, pre-operative heart rate; OLV, one-lung ventilation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-etm-08-05-1628" orientation="portrait" position="float"><label>Table II</label><caption><p>Distribution of types of surgical procedures.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Type of procedure</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group Arndt (n)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group DLT (n)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">VATS</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Wedge resection</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lobectomy</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Segmentectomy</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pneumonectomy</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mediastinal mass resection</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Esophageal procedures</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">4</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-etm-08-05-1628"><p>Group Arndt, n=26; Group DLT, n=29. No significant differences were identified between the two groups with regard to type of procedure. DLT, double-lumen tube; VATS, video-assisted thoracic surgery.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIII-etm-08-05-1628" orientation="portrait" position="float"><label>Table III</label><caption><p>Airway parameters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Parameter</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group Arndt</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group DLT</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Mallampati grade</td><td valign="top" align="center" rowspan="1" colspan="1">2.3&#x000b1;1.2</td><td valign="top" align="center" rowspan="1" colspan="1">2.2&#x000b1;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.82</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cormack grade</td><td valign="top" align="center" rowspan="1" colspan="1">2.5&#x000b1;1.4</td><td valign="top" align="center" rowspan="1" colspan="1">2.3&#x000b1;1.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.72</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intubation attempts (n)</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x000b1;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.1&#x000b1;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.59</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Intubation duration (min)</td><td valign="top" align="center" rowspan="1" colspan="1">3.3&#x000b1;0.3</td><td valign="top" align="center" rowspan="1" colspan="1">3.4&#x000b1;0.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Positioning attempts (n)</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x000b1;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x000b1;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Positioning duration (min)</td><td valign="top" align="center" rowspan="1" colspan="1">5.2&#x000b1;0.7</td><td valign="top" align="center" rowspan="1" colspan="1">3.0&#x000b1;0.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adjustments (n)</td><td valign="top" align="center" rowspan="1" colspan="1">0.7&#x000b1;0.2</td><td valign="top" align="center" rowspan="1" colspan="1">0.4&#x000b1;0.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-etm-08-05-1628"><p>Values are presented as the mean &#x000b1; standard deviation. Positioning, the positioning of the Arndt endobronchial blocker or DLT to facilitate one-lung ventilation; Adjustments, the adjustment of the Arndt endobronchial blocker or DLT due to inadequate lung isolation during surgery; DLT, double-lumen tube.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIV-etm-08-05-1628" orientation="portrait" position="float"><label>Table IV</label><caption><p>Respiratory parameters of the two groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="2" valign="bottom" align="center" rowspan="1">PAP (mmHg)</th><th colspan="2" valign="bottom" align="center" rowspan="1">Lung compliance (ml/cmH<sub>2</sub>O)</th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th colspan="2" valign="bottom" align="left" rowspan="1">
<hr/></th><th colspan="2" valign="bottom" align="left" rowspan="1">
<hr/></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Time</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group Arndt</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group DLT</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group Arndt</th><th valign="bottom" align="center" rowspan="1" colspan="1">Group DLT</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 1</td><td valign="top" align="left" rowspan="1" colspan="1">16.9&#x000b1;3.7</td><td valign="top" align="center" rowspan="1" colspan="1">18.4&#x000b1;3.3</td><td valign="top" align="left" rowspan="1" colspan="1">42.1&#x000b1;14.1</td><td valign="top" align="left" rowspan="1" colspan="1">47.7&#x000b1;11.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 2</td><td valign="top" align="left" rowspan="1" colspan="1">19.3&#x000b1;3.8</td><td valign="top" align="center" rowspan="1" colspan="1">19.7&#x000b1;3.4</td><td valign="top" align="left" rowspan="1" colspan="1">35.7&#x000b1;7.8</td><td valign="top" align="left" rowspan="1" colspan="1">41.5&#x000b1;9.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OLV 5</td><td valign="top" align="left" rowspan="1" colspan="1">19.3&#x000b1;3.6<xref rid="tfn6-etm-08-05-1628" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">19.7&#x000b1;3.6</td><td valign="top" align="left" rowspan="1" colspan="1">35.7&#x000b1;7.8</td><td valign="top" align="left" rowspan="1" colspan="1">41.5&#x000b1;9.5</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OLV 20</td><td valign="top" align="left" rowspan="1" colspan="1">24.6&#x000b1;4.8</td><td valign="top" align="center" rowspan="1" colspan="1">25.0&#x000b1;3.9</td><td valign="top" align="left" rowspan="1" colspan="1">25.7&#x000b1;9.8</td><td valign="top" align="left" rowspan="1" colspan="1">27.8&#x000b1;7.6</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OLV 60</td><td valign="top" align="left" rowspan="1" colspan="1">24.7&#x000b1;4.9</td><td valign="top" align="center" rowspan="1" colspan="1">25.5&#x000b1;3.8</td><td valign="top" align="left" rowspan="1" colspan="1">25.7&#x000b1;8.9</td><td valign="top" align="left" rowspan="1" colspan="1">25.8&#x000b1;6.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 5</td><td valign="top" align="left" rowspan="1" colspan="1">24.9&#x000b1;4.3</td><td valign="top" align="center" rowspan="1" colspan="1">26.3&#x000b1;3.3</td><td valign="top" align="left" rowspan="1" colspan="1">26.0&#x000b1;8.8</td><td valign="top" align="left" rowspan="1" colspan="1">26.3&#x000b1;7.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 10</td><td valign="top" align="left" rowspan="1" colspan="1">20.4&#x000b1;4.9</td><td valign="top" align="center" rowspan="1" colspan="1">19.9&#x000b1;4.7</td><td valign="top" align="left" rowspan="1" colspan="1">43.0&#x000b1;17.8</td><td valign="top" align="left" rowspan="1" colspan="1">42.4&#x000b1;13.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 20</td><td valign="top" align="left" rowspan="1" colspan="1">22.2&#x000b1;5.2</td><td valign="top" align="center" rowspan="1" colspan="1">21.1&#x000b1;4.5</td><td valign="top" align="left" rowspan="1" colspan="1">37.6&#x000b1;17.7</td><td valign="top" align="left" rowspan="1" colspan="1">41.2&#x000b1;12.8</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-etm-08-05-1628"><p>Values are presented as the mean &#x000b1; standard deviation.</p></fn><fn id="tfn6-etm-08-05-1628"><label>a</label><p>P&#x0003c;0.05 versus Group DLT.</p></fn><fn id="tfn7-etm-08-05-1628"><p>DLV 1, 2, 5, 10 and 20 refer to the time-points at 1, 2, 5, 10 and 20 min of DLV, respectively; OLV 5, 20 and 60 refer to the time-points at 5, 20 and 60 min of OLV, respectively. PAP, peak airway pressure; DLT, double-lumen tube; DLV, double-lung ventilation; OLV, one-lung ventilation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tV-etm-08-05-1628" orientation="portrait" position="float"><label>Table V</label><caption><p>Oxygenation and lung isolation of the two groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Evaluation measure</th><th valign="bottom" align="center" rowspan="1" colspan="1">Arndt</th><th valign="bottom" align="center" rowspan="1" colspan="1">DLT</th><th valign="bottom" align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Pre-op PaO<sub>2</sub>/FiO<sub>2</sub></td><td valign="top" align="center" rowspan="1" colspan="1">400&#x000b1;52</td><td valign="top" align="center" rowspan="1" colspan="1">362&#x000b1;62</td><td valign="top" align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OLV 20 PaO<sub>2</sub>/FiO<sub>2</sub></td><td valign="top" align="center" rowspan="1" colspan="1">209&#x000b1;89</td><td valign="top" align="center" rowspan="1" colspan="1">184&#x000b1;82</td><td valign="top" align="center" rowspan="1" colspan="1">0.29</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DLV 20 PaO<sub>2</sub>/FiO<sub>2</sub></td><td valign="top" align="center" rowspan="1" colspan="1">461&#x000b1;60</td><td valign="top" align="center" rowspan="1" colspan="1">454&#x000b1;65</td><td valign="top" align="center" rowspan="1" colspan="1">0.65</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average exposure score</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x000b1;0.4</td><td valign="top" align="center" rowspan="1" colspan="1">1.1&#x000b1;0.3</td><td valign="top" align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Average lung collapse score</td><td valign="top" align="center" rowspan="1" colspan="1">1.2&#x000b1;0.6</td><td valign="top" align="center" rowspan="1" colspan="1">1.1&#x000b1;0.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.54</td></tr></tbody></table><table-wrap-foot><fn id="tfn8-etm-08-05-1628"><p>Values are presented as the mean &#x000b1; standard deviation. DLT, double-lumen tube; PaO<sub>2</sub>/FiO<sub>2</sub>, the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen; Pre-op, pre-operative; OLV 20, at 20 min of one lung ventilation; DLV 20, at 20 min of double-lung ventilation following lung isolation.</p></fn></table-wrap-foot></table-wrap></floats-group></article>